Vistagen Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Vistagen Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • Vistagen Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$12.1M, a 73.4% decline year-over-year.
  • Vistagen Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$38.2M, a 17.9% increase year-over-year.
  • Vistagen Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$33M, a 44.3% increase from 2022.
  • Vistagen Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$59.3M, a 24% decline from 2021.
  • Vistagen Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$47.8M, a 166% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$33M +$26.2M +44.3% Apr 1, 2023 Mar 31, 2024 10-K 2024-06-11
2022 -$59.3M -$11.5M -24% Apr 1, 2022 Mar 31, 2023 10-K 2024-06-11
2021 -$47.8M -$29.8M -166% Apr 1, 2021 Mar 31, 2022 10-K 2023-06-28
2020 -$17.9M +$2.87M +13.8% Apr 1, 2020 Mar 31, 2021 10-K 2022-06-23
2019 -$20.8M +$3.75M +15.3% Apr 1, 2019 Mar 31, 2020 10-K 2021-06-29
2018 -$24.6M -$10.4M -72.9% Apr 1, 2018 Mar 31, 2019 10-K 2020-06-30
2017 -$14.2M -$3.95M -38.6% Apr 1, 2017 Mar 31, 2018 10-K 2019-06-25
2016 -$10.2M +$7.6M +42.6% Apr 1, 2016 Mar 31, 2017 10-K 2018-06-26
2015 -$17.9M -$11.1M -163% Apr 1, 2015 Mar 31, 2016 10-K 2017-06-29
2014 -$6.78M -$1.75M -34.8% Apr 1, 2014 Mar 31, 2015 10-K 2016-06-24
2013 -$5.03M +$1.76M +26% Apr 1, 2013 Mar 31, 2014 10-K 2015-06-29
2012 -$6.79M +$2.25M +24.9% Apr 1, 2012 Mar 31, 2013 10-K 2014-06-25
2011 -$9.04M -$2.48M -37.8% Apr 1, 2011 Mar 31, 2012 10-K 2013-07-18
2010 -$6.56M Apr 1, 2010 Mar 31, 2011 10-K 2012-07-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.